5-Amino-o-cresol | CAS:2835-95-2

We serve 5-Amino-o-cresol CAS:2835-95-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
5-Amino-o-cresol

Chemical Name:5-Amino-o-cresol
CAS.NO:2835-95-2
Synonyms:5-Amino-2-methylphenol; 2-hydroxy-p-toluidine; 
5-AMINO-ORTHO-CRESOL; 5-AMINO-2-CRESOL; 2-methyl-5-amino-phenol;
Molecular Formula:C7H9NO
Molecular Weight:123.15200
 
Physical and Chemical Properties:
Density:1.157;
Melting point:160-162oC;
Boiling point:268.6oC;
Flash point:116.3oC;
Index of Refraction:1.616;
 
Specification:
Appearance:Light yellow crystalline powder
Purity(HPLC):≥99.5%
Ash:≤0.1%
Loss on drying:≤0.5%
Fe content:≤20ppm
Heavy metal:≤5ppm
Moisture:≤0.5%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Hair dyes intermediate
 



Contact us for information like 5-Amino-o-cresol chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-methyl-5-amino-phenol physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,5-Amino-2-methylphenol Use and application,5-AMINO-ORTHO-CRESOL technical grade,usp/ep/jp grade.


Related News: Optimize the reaction and improve the production process to reduce the production cost. At the same time, strengthen the determination and analysis of impurities to improve product quality.2-Aminoethyldiisopropylamine manufacturer The downstream industry of the pharmaceutical intermediate industry is mainly the production of APIs, and the relationship between APIs and preparations is in the upstream and downstream industry chain. The consumer demand for downstream preparations will directly affect the demand for APIs.2-Azabicyclo[2.2.1]hept-5-en-3-one supplier “This is particularly important in reducing overall disease burden. Moreover, this strategic decision will not only strengthen our diabetes portfolio but also help consolidate our position as the fastest-growing player in the anti-diabetes segment,” Mankind Pharma Director of Marketing Sanjay Koul said in a statement.3,5-Dichloropyridine-2-carbonitrile vendor “This is particularly important in reducing overall disease burden. Moreover, this strategic decision will not only strengthen our diabetes portfolio but also help consolidate our position as the fastest-growing player in the anti-diabetes segment,” Mankind Pharma Director of Marketing Sanjay Koul said in a statement.Since inception in 2004, ICIG has acquired 15 businesses, all of which have origins in major global chemical or pharmaceutical corporations and are independently managed.